Related Experiment Video
Updated: Aug 20, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis
Mike Thomas1, Vasilisa Sazonov Kocevar, Qiaoyi Zhang
1Department of General Practice and Primary Care, University of Aberdeen, Foresterhill Health Centre, Westburn Road, Aberdeen, United Kingdom.
Insights
Children with asthma and allergic rhinitis (AR) use more healthcare resources and incur higher prescription costs. A unified treatment approach for both conditions may reduce overall healthcare expenditures.
Area of Science:
- Pediatric Allergy and Immunology
- Respiratory Medicine
- Health Services Research
Background:
- Asthma and allergic rhinitis (AR) are common childhood conditions.
- Comorbid allergic rhinitis significantly impacts asthma management and healthcare utilization.
- Understanding the incremental burden of AR in asthmatic children is crucial for resource allocation.
Purpose of the Study:
- To quantify the additional healthcare resource use associated with allergic rhinitis in children diagnosed with asthma.
- To determine the impact of comorbid allergic rhinitis on hospitalizations, general practitioner (GP) visits, and prescription drug costs in pediatric asthma patients.
Main Methods:
- Population-based historical cohort study utilizing UK general practice database records from 1998-2001.
- Included children aged 6-15 years with asthma and at least one asthma-related GP visit.
- Compared healthcare resource use (hospitalizations, GP visits, prescription costs) between children with asthma alone and those with comorbid allergic rhinitis.
Main Results:
- 19.7% of 9522 children with asthma also had allergic rhinitis.
- Children with comorbid allergic rhinitis had more GP visits (4.4 vs 3.4) and higher asthma hospitalization rates (1.4% vs 0.5%).
- Allergic rhinitis independently predicted asthma hospitalization (OR: 2.34) and increased GP visits, asthma drug costs (average increase £6.7), irrespective of asthma severity.
Conclusions:
- Comorbid allergic rhinitis significantly increases healthcare resource utilization and prescription costs in children with asthma.
- The findings support a unified treatment strategy for asthma and allergic rhinitis to potentially reduce healthcare burdens.
- Implementing guidelines like the Allergic Rhinitis and Its Impact on Asthma (ARIA) initiative may improve patient outcomes and cost-effectiveness.
Objective:
To determine the incremental effect of allergic rhinitis on health care resource use in children with asthma.
Design:
Population-based historical cohort study.
Setting:
Data in a general practice database in the United Kingdom during 1998 to 2001.
Patients:
Children 6 to 15 years old with asthma and with >or=1 asthma-related visits to a general practitioner (GP) during a 12-month follow-up period.
Main Outcome Measures:
Asthma-related hospitalizations, GP visits, and prescription drug costs during the 12-month follow-up period for patients with and without comorbid allergic rhinitis.
Results:
Of 9522 children with asthma, 1879 (19.7%) had allergic rhinitis recorded in the GP medical records. Compared with children with asthma alone, children with comorbid allergic rhinitis experienced more GP visits (4.4 vs 3.4) and more of them were hospitalized for asthma (1.4% vs 0.5%) during the 12-month follow-up period. In multivariable regression analyses, comorbid allergic rhinitis was an independent predictor of hospitalization for asthma (odds ratio: 2.34; 95% confidence interval [CI]: 1.41-3.91) and was associated with increases in the number of asthma-related GP visits (mean increase: 0.53; 95% CI: 0.52-0.54) and asthma drug costs (mean increase pound: 6.7; 95% CI: 6.5-7.0). The association between allergic rhinitis and higher costs of prescriptions for asthma drugs was independent of asthma severity, measured indirectly by the intensity of use of asthma drugs.
Conclusions:
Children with comorbid allergic rhinitis incurred greater prescription drug costs and experienced more GP visits and hospitalizations for asthma than did children with asthma alone. A unified treatment strategy for asthma and allergic rhinitis, as recommended by the Allergic Rhinitis and Its Impact on Asthma initiative, might reduce the costs of treating these conditions.
Related Concept Videos
Asthma I: Introduction
Asthma-I: Introduction
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma III: Clinical Manifestations
